FGAM
MGNX icon

Financial Gravity Asset Management’s MacroGenics MGNX Stock Holding History

Financial Gravity Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2
Closed -$31 – 1658
2024
Q1 		$31 Buy
2
+1
+100% +$15 ﹤0.01% 1081
2023
Q4 		$5 Buy
+1
New +$7 ﹤0.01% 1313
2021
Q3 		$21K Hold
1
– – 0.01% 798
2021
Q2 		$27K Buy
+1
New +$29 0.01% 742
2019
Q4 		– Sell
-12
Closed – – 1591
2019
Q3 		$0 Buy
+12
New +$173 ﹤0.01% 1419

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Financial Gravity Asset Management's MGNX Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 2 shares — an estimated $31 sold.

Financial Gravity Asset Management first reported a position in MGNX in Q3 2019 and held it in 5 quarters. The position peaked at $27K in Q2 2021. 147 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • Financial Gravity Asset Management reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 2 MacroGenics shares in Q2 2024, an estimated $31.
  • Financial Gravity Asset Management first reported a position in MacroGenics in Q3 2019 and held it in 5 quarters.
  • Financial Gravity Asset Management's MacroGenics position peaked at $27K in Q2 2021.
  • 147 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.